Hepatic metabolic regulation by nuclear factor E4BP4
- PMID: 33434146
- PMCID: PMC7808567
- DOI: 10.1530/JME-20-0239
Hepatic metabolic regulation by nuclear factor E4BP4
Abstract
Discovered as a b-ZIP transcription repressor 30 years ago, E4 promoter-binding protein 4 (E4BP4) has been shown to play critical roles in immunity, circadian rhythms, and cancer progression. Recent research has highlighted E4BP4 as a novel regulator of metabolisms in various tissues. In this review, we focus on the function and mechanisms of hepatic E4BP4 in regulating lipid and glucose homeostasis, bile metabolism, as well as xenobiotic metabolism. Finally, E4BP4-specific targets will be discussed for the prevention and treatment of metabolic disorders.
Keywords: E4BP4; glucose; insulin; lipid; metabolism.
Conflict of interest statement
Declaration of Interest
All the authors declare no financial interest or potential conflict of interest.
Figures


Similar articles
-
Regulation of bile acid synthesis by the nuclear receptor Rev-erbalpha.Gastroenterology. 2008 Aug;135(2):689-98. doi: 10.1053/j.gastro.2008.05.035. Epub 2008 May 15. Gastroenterology. 2008. PMID: 18565334
-
E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis.J Lipid Res. 2016 Jul;57(7):1219-30. doi: 10.1194/jlr.M067181. Epub 2016 Jun 1. J Lipid Res. 2016. PMID: 27252523 Free PMC article.
-
Transcriptional repressor E4-binding protein 4 (E4BP4) regulates metabolic hormone fibroblast growth factor 21 (FGF21) during circadian cycles and feeding.J Biol Chem. 2010 Nov 19;285(47):36401-9. doi: 10.1074/jbc.M110.172866. Epub 2010 Sep 17. J Biol Chem. 2010. PMID: 20851878 Free PMC article.
-
The role of basic leucine zipper transcription factor E4BP4 in cancer: a review and update.Mol Biol Rep. 2024 Jan 9;51(1):91. doi: 10.1007/s11033-023-09079-9. Mol Biol Rep. 2024. PMID: 38193973 Review.
-
The role of basic leucine zipper transcription factor E4BP4 in the immune system and immune-mediated diseases.Clin Immunol. 2017 Jul;180:5-10. doi: 10.1016/j.clim.2017.03.013. Epub 2017 Mar 30. Clin Immunol. 2017. PMID: 28365317 Review.
Cited by
-
A new border for circadian rhythm gene NFIL3 in diverse fields of cancer.Clin Transl Oncol. 2023 Jul;25(7):1940-1948. doi: 10.1007/s12094-023-03098-5. Epub 2023 Feb 15. Clin Transl Oncol. 2023. PMID: 36788184 Review.
-
E4bp4-Cyp3a11 axis in high-fat diet-induced obese mice with weight fluctuation.Nutr Metab (Lond). 2024 May 27;21(1):30. doi: 10.1186/s12986-024-00803-1. Nutr Metab (Lond). 2024. PMID: 38802929 Free PMC article.
-
Dangua Fang induces anti-glucolipid metabolism disorder effects similar to those of direct NFIL3 inhibition.Front Microbiol. 2025 Mar 19;16:1557345. doi: 10.3389/fmicb.2025.1557345. eCollection 2025. Front Microbiol. 2025. PMID: 40177474 Free PMC article.
-
Ferroptosis and inflammation are modulated by the NFIL3-ACSL4 axis in sepsis associated-acute kidney injury.Cell Death Discov. 2024 Aug 4;10(1):349. doi: 10.1038/s41420-024-02113-0. Cell Death Discov. 2024. PMID: 39097582 Free PMC article.
-
NFIL3 and its immunoregulatory role in rheumatoid arthritis patients.Front Immunol. 2022 Nov 11;13:950144. doi: 10.3389/fimmu.2022.950144. eCollection 2022. Front Immunol. 2022. PMID: 36439145 Free PMC article.
References
-
- Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS & Maratos-Flier E 2007. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 5 426–437. - PubMed
-
- Bougarne N, Weyers B, Desmet SJ, Deckers J, Ray DW, Staels B & De Bosscher K 2018. Molecular Actions of PPARalpha in Lipid Metabolism and Inflammation. Endocr Rev 39 760–802. - PubMed
-
- Brown MS & Goldstein JL 1997. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89 331–340. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources